Table 3 Predictors of HIV/HPV co-infection
Variable | HIV/HPV co-infection | OR (95% CI) | P value | AOR (95% CI) | P value | |
|---|---|---|---|---|---|---|
Positive | Total | |||||
n (%) | N (%) | |||||
Age (years)* | ||||||
 25–34 | 20 (50.0) | 40 (100.0) | 1 |  | 1 |  |
 35–44 | 43 (45.3) | 95 (100.0) | 0.83 (0.39–1.73) | 0.615 | 0.43 (0.16–1.16) | 0.096 |
 45–54 | 47 (43.9) | 107 (100.0) | 0.78 (0.38–1.62) | 0.511 | 0.50 (0.18–1.34) | 0.168 |
  ≥ 55 | 31 (35.2) | 88 (100.0) | 0.54 (0.25–1.16) | 0.116 | 0.23 (0.07–0.71) | 0.011 |
Marital status | ||||||
 Single | 39 (52.0) | 75 (100.0) | 1 |  | 1 |  |
 Married/cohabiting | 45 (36.3) | 124 (100.0) | 0.53 (0.29–0.94) | 0.031 | 0.67 (0.32–1.39) | 0.278 |
 Widowed/divorced | 57 (43.5) | 131 (100.0) | 0.71 (0.40–1.26) | 0.241 | 1.14 (0.52–2.48) | 0.739 |
Heard of cervical cancer screening? | ||||||
 Yes | 50 (36.8) | 136 (100.0) | 1 |  | 1 |  |
 No | 91 (46.9) | 194 (100.0) | 1.52 (0.97–2.38) | 0.067 | 2.80 (1.46–5.35) | 0.002 |
Duration on ART | Â | Â | Â | Â | Â | Â |
  < 1 | 24 (46.2) | 52 (100.0) | 1 |  | 1 |  |
 1–4 | 57 (35.6) | 160 (100.0) | 0.65 (0.34–1.22) | 0.176 | 0.32 (0.08–1.30) | 0.112 |
 5–10 | 41 (54.7) | 75 (100.0) | 1.41 (0.69–2.86) | 0.346 | 0.68 (0.16–2.90) | 0.600 |
  ≥ 11 | 19 (44.2) | 43 (100.0) | 0.92 (0.41–2.08) | 0.848 | 0.50 (0.11–2.29) | 0.111 |
HIV viral load (copies/ml) | ||||||
  < 1000 | 70 (37.2) | 188 (100.0) | 1 |  | 1 |  |
  ≥ 1000 | 62 (40.3) | 132 (100.0) | 4.75 (2.69–8.39) |  < 0.001 | 5.58 (2.89–10.78) |  < 0.001 |